Product Information
Registration Status: ActiveSIN13202P
RABIPUR is approved to be sold in Singapore with effective from 2006-04-26. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN13202P.
This product contains Rabies Virus Potency2.5IU in the form of INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. It is approved for INTRAMUSCULAR use.
This product is manufactured by Novartis Vaccines in GERMANY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Rabies virus inactivated antigen, A is an inactivated virus vacine for the intramuscular injection. It is an active immunization against rabies that can be administered pre- or post-exposure to the rabies virus.
Active Ingredient/Synonyms
Rabies virus strain flury lep antigen (propiolactone inactivated) | Rabies virus vaccine flury-lep strain | Rabies virus inactivated antigen, A |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.